糖尿病、合并症及体重指数与子宫内膜癌患者全因及病因别死亡风险的关联
该队列纳入1359例2005至2007年确诊的澳大利亚子宫内膜癌患者,中位随访7.1年,179例(13%)死亡,其中123例(69%)死于子宫内膜癌。糖尿病与癌因死亡风险升高相关(HR 2.09,95%CI 1.31-3.35),非肥胖糖尿病患者风险更高(HR 4.13,95%CI 2.20-7.76);≥2种其他合并症亦与癌因死亡风险升高相关(HR 3.09,95%CI 1.21-7.89)。
要点
- 糖尿病与子宫内膜癌癌因死亡风险升高相关(HR 2.09,95%CI 1.31-3.35)。
- 非肥胖合并糖尿病者癌因死亡风险更高(HR 4.13,95%CI 2.20-7.76)。
- ≥2种其他合并症与癌因死亡风险升高相关(HR 3.09,95%CI 1.21-7.89)。
核心结论
- 糖尿病、其他合并症和肥胖是子宫内膜癌患者死亡的负性预测因素,但癌因死亡与非癌因死亡的风险模式不同。
研究设计与样本
- 队列研究,纳入2005至2007年确诊的1359例澳大利亚子宫内膜癌患者,采用Cox比例风险回归估计风险比(HR)及95%CI。
主要发现
- 中位随访7.1年,179例(13%)死亡,其中123例(69%)死于子宫内膜癌。
- 糖尿病与癌因死亡风险升高相关(HR 2.09,95%CI 1.31-3.35),非肥胖糖尿病患者风险更高(HR 4.13,95%CI 2.20-7.76)。
- ≥2种其他合并症(不包括糖尿病)与癌因死亡风险升高相关(HR 3.09,95%CI 1.21-7.89)。
- 体重指数升高、糖尿病及其他合并症与全因死亡和非癌因死亡风险显著升高相关。
- 低级别子宫内膜样癌与高级别子宫内膜样/非子宫内膜样癌患者的风险模式大致相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although endometrial cancer (EC) is associated with relatively good survival rates overall, women diagnosed with high-risk subtypes have poor outcomes. We examined the relationship between lifestyle factors and subsequent all-cause, cancer-specific and non-cancer related survival. METHODS: In a cohort of 1359 Australian women diagnosed with incident EC between 2005 and 2007 pre-diagnostic information was collected by interview at recruitment. Clinical and survival information was abstracted from women's medical records, supplemented by linkage to the Australian National Death Index. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause and cause-specific survival (EC death vs. non-EC death) associated with each exposure, overall and by risk group (low-grade endometrioid vs. high-grade endometrioid and non-endometrioid). RESULTS: After a median follow-up of 7.1 years, 179 (13%) women had died, with 123 (69%) deaths from EC. As expected, elevated body mass index (BMI), diabetes and the presence of other co-morbidities were associated with a significantly increased risk of all-cause and non-cancer related death. Women with diabetes had higher cancer-specific mortality rates (HR 2.09, 95% CI 1.31-3.35), particularly those who had were not obese (HR 4.13, 95% CI 2.20-7.76). The presence of ≥2 other co-morbidities (excluding diabetes) was also associated with increased risk of cancer-specific mortality (HR 3.09, 95% CI 1.21-7.89). The patterns were generally similar for women with low-grade and high-grade endometrioid/non-endometrioid EC. CONCLUSION: Our findings demonstrate the importance of diabetes, other co-morbidities and obesity as negative predictors of mortality among women with EC but that the risks differ for cancer-specific and non-cancer related mortality.
引用
- Nagle CM, Crosbie EJ, Brand A, et al. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer. Gynecol Oncol. 2018. PMID: 29706522. doi:10.1016/j.ygyno.2018.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。